← The Wire
NBIXNasdaq
NEUROCRINE BIOSCIENCES INC
Biological Products, (No Diagnostic Substances) · DE · CIK 914475
Neurocrine Biosciences discovers, develops, and commercializes treatments for neurological, psychiatric, endocrine, and immunological disorders
red 8-K · 90d
$16.06B
Market cap
$170.00
Last close
+0.9%
1D
+5.2%
5D
1.4M
Volume
Price · last 39 sessions+26.8%
May 4L $134.07 · H $170.00Jun 29
159
Total filings
May 28, 2026
Last filing
12/31
Fiscal year end
DEFA14ADEFA14AApr 15, 2026DEFA14ADEFA14AApr 9, 2025DEFA14ADEFA14AApr 10, 2024DEFA14ADEFA14AMay 2, 2023DEFA14ADEFA14AApr 5, 2023DEFA14ADEFA14AApr 7, 2022DEFA14ADEFA14AApr 9, 2021DEFA14ADEFA14AApr 9, 2020DEFA14ADEFA14AApr 4, 2018
Insider Activity
In the 90 days to Jan 16, 2026: 7 sold $14.6M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 16, 2026 | Gano KyleChief Executive Officer | Sell | 34,588 | $132.70 | $4.6M |
| Jan 16, 2026 | Gano KyleChief Executive Officer | Sell | 1,812 | $132.71 | $240K |
| Dec 16, 2025 | Norwalk Leslie VDirector | Sell | 1,190 | $155.09 | $185K |
| Dec 15, 2025 | Norwalk Leslie VDirector | Sell | 5,000 | $152.23 | $761K |
| Dec 8, 2025 | Lippoldt DarinChief Legal Officer | Sell | 4,376 | $159.65 | $699K |
| Dec 3, 2025 | Lyons Gary ADirector | Sell | 15,000 | $152.61 | $2.3M |
| Nov 28, 2025 | Benevich EricChief Commercial Officer | Sell | 5,970 | $151.74 | $906K |
| Nov 25, 2025 | Morrow George JDirector | Sell | 15,000 | $143.37 | $2.2M |
| Nov 5, 2025 | Rastetter William HDirector | Sell | 18,000 | $151.82 | $2.7M |
| Nov 4, 2025 | Gano KyleChief Executive Officer | Sell | 300 | $141.97 | $43K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance